Takayuki Katsube
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Semi-Mechanistic Modeling of S-531011, a Humanized Anti-CCR8 Monoclonal Antibody, for Prediction of CCR8 Receptor Occupancy in Human Tumor Tissues.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 06, 2026
Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study.
Journal: The Pediatric infectious disease journal
Published: September 04, 2024
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.
Journal: Infectious diseases and therapy
Published: August 13, 2024
Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: June 21, 2024
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor.
Journal: Infectious diseases and therapy
Published: January 24, 2024
Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model-based approach.
Journal: Pharmacology research & perspectives
Published: November 09, 2023
Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
Journal: Clinical pharmacokinetics
Published: June 06, 2022
Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance.
Journal: Advances in therapy
Published: May 12, 2022
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
Journal: Clinical pharmacokinetics
Published: October 31, 2021
Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
Journal: The Journal of antimicrobial chemotherapy
Published: September 17, 2021
Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects.
Journal: Journal of clinical pharmacology
Published: August 17, 2021
Last Updated: 09/26/2026